Fremanezumab
( DrugBank: Fremanezumab / KEGG DRUG: Fremanezumab )
2 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
124 | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
226 | Interstitial cystitis with Hunners ulcer | 2 |
124. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
Clinical trials : 17 / Drugs : 19 - (DrugBank : 9) / Drug target genes : 6 - Drug target pathways : 24
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
226. Interstitial cystitis with Hunners ulcer
Clinical trials : 163 / Drugs : 158 - (DrugBank : 58) / Drug target genes : 79 - Drug target pathways : 142
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|